Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 1.042T	--
Jan 30, 2025	2025/Q3	-- / 1.132T	--
Oct 31, 2024	2025/Q2	1.176T / 1.079T	--
Jul 31, 2024	2025/Q1	1.208T / 1.081T	--
May 9, 2024	2024/Q4	1.051T / 899.902B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 1.042T--

Jan 30, 20252025/Q3-- / 1.132T--

Oct 31, 20242025/Q21.176T / 1.079T--

Jul 31, 20242025/Q11.208T / 1.081T--

May 9, 20242024/Q41.051T / 899.902B--

Unlock Free Earnings Estimates

Open Account

Takeda Pharmaceutical Earnings Reports

Takeda Pharmaceutical: Confirmatory letter.

Oct 31 02:16 ET

Takeda Pharmaceutical: Interim report - 148th period (2024/04/01 - 2025/03/31)

Oct 31 02:14 ET

Takeda Pharmaceutical: Notice Concerning Revisions to Full Year Consolidated Financial Results (IFRS)

Oct 31 02:00 ET

Takeda Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [IFRS] (consolidated)

Oct 31 02:00 ET

Symbol Price % Chg

Silver Egg Technology

3961

1010 +17.44%